v3.22.2.2
Stockholders’ Equity (Details)
 3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
class_of_stock
$ / shares
shares
Jul. 27, 2022
USD ($)
$ / shares
shares
May 05, 2022
USD ($)
Apr. 25, 2022
USD ($)
Nov. 11, 2020
$ / shares
shares
Nov. 11, 2020
USD ($)
$ / shares
shares
Feb. 19, 2020
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
class_of_stock
$ / shares
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
class_of_stock
$ / shares
shares
Sep. 30, 2021
USD ($)
Dec. 31, 2021
$ / shares
shares
May 17, 2021
USD ($)
$ / shares
shares
Stockholders' Equity [Line Items]                          
Number of classes of stock | class_of_stock 2             2   2      
Authorized capital stock (in Shares) | shares                   101,000,000      
Common stock, shares authorized (in Shares) | shares 100,000,000             100,000,000   100,000,000   100,000,000  
Common stock par value (in Dollars per share) | $ / shares $ 0.0001             $ 0.0001   $ 0.0001   $ 0.0001  
Preferred stock, shares authorized (in Shares) | shares 1,000,000             1,000,000   1,000,000      
Preferred stock par value (in Dollars per share) | $ / shares $ 0.0001             $ 0.0001   $ 0.0001      
Gross proceeds from offering   $ 14,000,000                      
Agent fee percentage                   6.00%      
Sale price (in Dollars per share) | $ / shares                         $ 50.00
Proceeds from common stock offering, net of offering costs                   $ 3,763,494 $ 0    
Warrants outstanding, term                         10 years
Class of warrant or right, commitment amount $ 3,200,000             $ 3,200,000   3,200,000      
Write-off of deferred financing costs               0 $ 0 43,562,847 0    
Total recurring fair value measurements $ 543,257             543,257 1,135,785 543,257 1,135,785    
Recurring fair value measurements, gain (loss) during period               $ 129,755 544,821 $ 834,691 615,049    
Purchase agreement, authorized amount                         $ 250,000,000
Grant date fair value of securities purchase agreement                         $ 12,600,000
Stonepeak                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued                         90.00%
Evolve                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued                         10.00%
Unit Purchase Option                          
Stockholders' Equity [Line Items]                          
Shares issued (in Dollars per share) | $ / shares             $ 100            
Exercisable units (in shares) | shares             316,250            
Options exercisable (in Dollars per share) | $ / shares             $ 11.50            
Aggregate exercise price             $ 3,636,875            
Number of shares included in a unit (in shares) | shares             1.1            
Unit Purchase Option | Minimum                          
Stockholders' Equity [Line Items]                          
Right to registration, period             5 years            
Unit Purchase Option | Maximum                          
Stockholders' Equity [Line Items]                          
Right to registration, period             7 years            
Investor                          
Stockholders' Equity [Line Items]                          
Common stock shares purchase (in Shares) | shares           1,425,000              
Purchase price per share value (in Dollars per share) | $ / shares         $ 10.00 $ 10.00              
PIPE                          
Stockholders' Equity [Line Items]                          
Sale of units (in Shares) | shares         1.9                
Sale price (in Dollars per share) | $ / shares         $ 11.50 $ 11.50              
Aggregate purchase price of common stock (in Dollars)           $ 14,250,000              
Stonepeak/Evolve Warrants - series B                          
Stockholders' Equity [Line Items]                          
Warrants outstanding, grant date fair value                         $ 12,800,000
Exercise price (in Dollars per share) | $ / shares $ 10.00             $ 10.00   $ 10.00      
Stonepeak/Evolve Warrants - series C                          
Stockholders' Equity [Line Items]                          
Warrants outstanding, grant date fair value                         5,600,000
Exercise price (in Dollars per share) | $ / shares 15.00             15.00   15.00      
Stonepeak/Evolve Warrants - series D                          
Stockholders' Equity [Line Items]                          
Warrants outstanding, grant date fair value                         4,800,000
Exercise price (in Dollars per share) | $ / shares 20.00             20.00   20.00      
Stonepeak/Evolve Warrants - series E                          
Stockholders' Equity [Line Items]                          
Warrants outstanding, grant date fair value                         3,800,000
Exercise price (in Dollars per share) | $ / shares 30.00             30.00   30.00      
Stonepeak/Evolve Warrants - series F                          
Stockholders' Equity [Line Items]                          
Warrants outstanding, grant date fair value                         $ 3,200,000
Exercise price (in Dollars per share) | $ / shares $ 40.00             40.00   $ 40.00      
Warrants                          
Stockholders' Equity [Line Items]                          
Sale of units (in Shares) | shares             5,750,000            
Write-off of deferred financing costs $ 31,000,000                        
Number of securities called by warrants (in shares) | shares   4,000,000                      
Exercise price (in Dollars per share) | $ / shares   $ 3.75                      
Stonepeak Warrants | Securities Purchase Agreement                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued                         90.00%
Write-off of deferred financing costs $ 12,600,000                        
Evolve Warrants | Securities Purchase Agreement                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued                         10.00%
Prefunded Warrant                          
Stockholders' Equity [Line Items]                          
Common stock par value (in Dollars per share) | $ / shares   $ 0.0001                      
Number of securities called by warrants (in shares) | shares   1,850,000                      
Class of warrant or right, number of securities called by each warrant | shares   1                      
Stonepeak/Evolve Warrants - series B                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares) | shares                         2,000,000
Exercise price (in Dollars per share) | $ / shares                         $ 10.00
Stonepeak/Evolve Warrants - series C                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares) | shares                         1,000,000
Exercise price (in Dollars per share) | $ / shares                         $ 15.00
Percent of warrants vested upon issuance                         50.00%
Percent of warrants vested upon additional capital expenditures                         50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                         $ 125,000,000
Stonepeak/Evolve Warrants - series D                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares) | shares                         1,000,000
Exercise price (in Dollars per share) | $ / shares                         $ 20.00
Percent of warrants vested upon issuance                         50.00%
Percent of warrants vested upon additional capital expenditures                         50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                         $ 250,000,000
Stonepeak/Evolve Warrants - series E                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares) | shares                         1,000,000
Exercise price (in Dollars per share) | $ / shares                         $ 30.00
Percent of warrants vested upon issuance                         50.00%
Percent of warrants vested upon additional capital expenditures                         50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                         $ 375,000,000
Stonepeak/Evolve Warrants - series F                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares) | shares                         1,000,000
Exercise price (in Dollars per share) | $ / shares                         $ 40.00
Percent of warrants vested upon issuance                         50.00%
Percent of warrants vested upon additional capital expenditures                         50.00%
Additional capital expenditure to trigger exercise of nonvested warrants                         $ 500,000,000
Shelf Registration                          
Stockholders' Equity [Line Items]                          
Gross proceeds from offering       $ 100,000,000                  
At The Market Offering                          
Stockholders' Equity [Line Items]                          
Gross proceeds from offering     $ 25,000,000                    
Agent fee percentage     3.00%                    
Sale of units (in Shares) | shares                   792,882      
Sale price (in Dollars per share) | $ / shares $ 4.97             $ 4.97   $ 4.97      
Proceeds from common stock offering, net of offering costs                   $ 3,800,000      
IPO | Newborn                          
Stockholders' Equity [Line Items]                          
Number of warrants per unit (in Shares) | shares             1            
Percent of one share of common stock             50.00%            
Class of warrant or right, number of securities called by each warrant | shares             1            
Private Placement | Newborn                          
Stockholders' Equity [Line Items]                          
Number of warrants per unit (in Shares) | shares             1            
Private Placement | Warrants                          
Stockholders' Equity [Line Items]                          
Aggregate share purchase (in Shares) | shares             272,500            
Private Warrants                          
Stockholders' Equity [Line Items]                          
Total recurring fair value measurements $ 12,000             $ 12,000 626,000 12,000 626,000    
Recurring fair value measurements, gain (loss) during period               $ 170,000 $ 557,000 $ 854,000 $ 627,228